Enrico Iaccino is currently enrolled at the University “Magna Graecia” of Catanzaro as an Associate Professor in Clinical Biochemistry (BIO12).  During his Ph.D., as a winner of two fellowships, one from the EFIS (European Federation of Immunological Societies) and the other from AIRC (Italian Association for Cancer Research), Prof. Iaccino worked at the Royal Free Campus (UCL) and investigating new peptide-based options for B cell neoplasia immunotherapy. In 2018, he won a Gilead-funded grant aimed at studying the role of tumor-derived exosomes in B lymphoproliferative neoplasia and, working on the validation of this research in the context of drug-resistant models. The research of Prof. Iaccino’s group is focused on the isolation and molecular characterization of exosomes as prognostic biomarkers in several diseases, such as hematological neoplasias, infectious diseases, and neurodegenerative diseases.